Skip to main content
Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.440
-0.040 (-2.70%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Metagenomi Therapeutics Revenue

In the year 2025, Metagenomi Therapeutics had annual revenue of $25.21M, down -51.79%. Metagenomi Therapeutics had revenue of $3.91M in the quarter ending December 31, 2025, a decrease of -59.32%.

Revenue (ttm)
$25.21M
Revenue Growth
-51.79%
P/S Ratio
2.15
Revenue / Employee
$211,849
Employees
119
Market Cap
54.17M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202525.21M-27.09M-51.79%
Dec 31, 202452.30M7.54M16.84%
Dec 31, 202344.76M27.56M160.21%
Dec 31, 202217.20M16.96M6,978.19%
Dec 31, 2021243.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cue Biopharma 27.47M
MindWalk Holdings 20.70M
Radiopharm Theranostics 10.86M
Hyperion DeFi 813.46K
iBio, Inc. 300.00K
Entera Bio 42.00K
Revenue Rankings

MGX News

More News